Efficacy of Levetiracetam in Essential Tremor

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Essential Tremor

In brief

Essential tremor poses one of the greatest therapeutic challenges to neurologists. This study will examine the effectiveness of the drug, levetiracetam or keppra, for the treatment of essential tremor.

Key facts

Study ID

NCT00620165

Run by

Southern California Institute for Research and Education

People needed

10

Starts

2005-01-01

Expected to finish

2008-03-01

Last updated by the study team

2009-04-17

Who can join

Age: 25 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of tremor for 5 or more years
• No other neurological problems

You may not qualify if…

• Prior stroke or other neurological disease, psychiatric problems
• History of renal disease
• Pregnancy

Where it is running

• VA Long Beach Healthcare System — Long Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.